Patents by Inventor Caroline Andrews

Caroline Andrews has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED ORTHOPOXVIRUS VECTORS
    Publication number: 20240132913
    Abstract: The disclosure relates to modified orthopoxvirus vectors, as well as methods of using the same for the treatment of various cancers. The disclosure provides modified orthopoxvirus vectors that exhibit various beneficial therapeutic activities, including enhanced oncolytic activity, spread of infection, immune evasion, tumor persistence, capacity for incorporation of exogenous DNA sequences and safety. The viruses we have discovered are also amenable to large scale manufacturing protocols.
    Type: Application
    Filed: September 4, 2023
    Publication date: April 25, 2024
    Applicants: OTTAWA HOSPITAL RESEARCH INSTITUTE, TURNSTONE BIOLOGICS CORP.
    Inventors: John C. Bell, Fabrice Le Boeuf, Michael S. Huh, Matthew Y. Tang, Adrian Pelin, Brian Andrew Keller, Caroline J. Breitbach, Michael F. Burgess, Steven H. Bernstein
  • Peptide hydrogels and use thereof
    Patent number: 11661439
    Abstract: This disclosure provides novel anionic amphiphilic ?-hairpin peptides that self-assemble under appropriate conditions to form a reversible gel-sol hydrogel that can be used, for example, to readily deliver protein therapeutics and cells by injection to a target location in a subject.
    Type: Grant
    Filed: December 17, 2017
    Date of Patent: May 30, 2023
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Joel Schneider, Scott Walsh, Stephen Miller, Yuji Yamada, Scott Durum, Caroline Andrews, Wenqing Li, Julie Hixon, Steven Tau
  • PEPTIDE HYDROGELS AND USE THEREOF
    Publication number: 20210079042
    Abstract: This disclosure provides novel anionic amphiphilic ?-hairpin peptides that self-assemble under appropriate conditions to form a reversible gel-sol hydrogel that can be used, for example, to readily deliver protein therapeutics and cells by injection to a target location in a subject.
    Type: Application
    Filed: December 17, 2017
    Publication date: March 18, 2021
    Applicants: Health and Human Services
    Inventors: Joel Schneider, Scott Walsh, Stephen Miller, Yuji Yamada, Scott Durum, Caroline Andrews, Wenqing Li, Julie Hixon, Steven Tau
  • Wireless communication device and system
    Patent number: 8620254
    Abstract: The present invention is directed to a wireless communications device that includes an antenna configured to receive an RF signal from an ambient environment. The antenna is characterized by an antenna impedance and the RF signal is characterized by a predetermined frequency. A passive mixer assembly is coupled to the antenna without an RF matching network. The passive mixer assembly is characterized by a passive mixer impedance presented to the antenna. The passive mixer assembly includes a plurality of baseband mixer ports. The passive mixer assembly is configured to downconvert the RF signal and provide a plurality of baseband signals. Each baseband signal of the plurality of baseband signals is directed out of a corresponding port of the plurality of baseband mixer ports and characterized by a predetermined phase of a plurality of predetermined phases. A baseband low noise amplifier (baseband-LNA) assembly is coupled to the passive mixer assembly.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: December 31, 2013
    Assignee: Cornell University
    Inventors: Alyosha Molnar, Caroline Andrews
  • WIRELESS COMMUNICATION DEVICE AND SYSTEM
    Publication number: 20130059556
    Abstract: The present invention is directed to a wireless communications device that includes an antenna configured to receive an RF signal from an ambient environment. The antenna is characterized by an antenna impedance and the RF signal is characterized by a predetermined frequency. A passive mixer assembly is coupled to the antenna without an RF matching network. The passive mixer assembly is characterized by a passive mixer impedance presented to the antenna. The passive mixer assembly includes a plurality of baseband mixer ports. The passive mixer assembly is configured to downconvert the RF signal and provide a plurality of baseband signals. Each baseband signal of the plurality of baseband signals is directed out of a corresponding port of the plurality of baseband mixer ports and characterized by a predetermined phase of a plurality of predetermined phases. A baseband low noise amplifier (baseband-LNA) assembly is coupled to the passive mixer assembly.
    Type: Application
    Filed: February 3, 2011
    Publication date: March 7, 2013
    Applicant: Cornell University - Cornell Center for Technology Enterprise & Commercialization (CCTEC)
    Inventors: Alyosha Molnar, Caroline Andrews